Gary R. Pitcairn

1.5k total citations
32 papers, 1.1k citations indexed

About

Gary R. Pitcairn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmaceutical Science. According to data from OpenAlex, Gary R. Pitcairn has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 5 papers in Pharmaceutical Science. Recurrent topics in Gary R. Pitcairn's work include Inhalation and Respiratory Drug Delivery (26 papers), Asthma and respiratory diseases (17 papers) and Respiratory and Cough-Related Research (7 papers). Gary R. Pitcairn is often cited by papers focused on Inhalation and Respiratory Drug Delivery (26 papers), Asthma and respiratory diseases (17 papers) and Respiratory and Cough-Related Research (7 papers). Gary R. Pitcairn collaborates with scholars based in United Kingdom, United States and Sweden. Gary R. Pitcairn's co-authors include Stephen P. Newman, Peter H. Hirst, Steve Newman, Demetri Pavia, Richard N. Dalby, M Silvasti, E. O’Keefe, Róbert Hermann, Paolo Ventura and Andrew R. Clark and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Gary R. Pitcairn

32 papers receiving 1.0k citations

Peers

Gary R. Pitcairn

PRM

PHYSI

Peter H. Hirst United Kingdom

Martyn F. Biddiscombe United Kingdom

N. R. Labiris Canada

Folke Morén United Kingdom

Joseph L. Rau United States

Ross Walenga United States

Chet Leach United States

K.P. Steed United Kingdom

David Prime United Kingdom

N Talaee United Kingdom

Peter H. Hirst United Kingdom

Gary R. Pitcairn

817 ×0.8

PRM

308 ×0.6

PHYSI

200 ×1.1

172 ×1.4

99 ×1.0

Citations per year, relative to Gary R. Pitcairn Gary R. Pitcairn (= 1×) peers Peter H. Hirst

Countries citing papers authored by Gary R. Pitcairn

Since Specialization

Citations

This map shows the geographic impact of Gary R. Pitcairn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Pitcairn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Pitcairn more than expected).

Fields of papers citing papers by Gary R. Pitcairn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Pitcairn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Pitcairn. The network helps show where Gary R. Pitcairn may publish in the future.

Co-authorship network of co-authors of Gary R. Pitcairn

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Pitcairn. A scholar is included among the top collaborators of Gary R. Pitcairn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Pitcairn. Gary R. Pitcairn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pilkington, Georgia A., Göran Frenning, Mikael Ekström, et al.. (2024). Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles. European Journal of Pharmaceutical Sciences. 200. 106828–106828. 6 indexed citations

Newman, Steve, et al.. (2012). Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration. International Journal of Pharmaceutics. 431(1-2). 39–44. 12 indexed citations

Clark, Andrew R., et al.. (2008). A Comparison of the Pulmonary Bioavailability of Powder and Liquid Aerosol Formulations of Salmon Calcitonin. Pharmaceutical Research. 25(7). 1583–1590. 23 indexed citations

Shrewsbury, Stephen B., et al.. (2008). Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. International Journal of Pharmaceutics. 356(1-2). 137–143. 11 indexed citations

Shrewsbury, Stephen B., et al.. (2007). Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans. Current Medical Research and Opinion. 23(12). 3177–3187. 23 indexed citations

Fleming, John, Gary R. Pitcairn, & Stephen P. Newman. (2006). Defining the lung outline from a gamma camera transmission attenuation map. Physics in Medicine and Biology. 51(7). 1791–1805. 3 indexed citations

Pitcairn, Gary R., et al.. (2005). Deposition of Corticosteroid Aerosol in the Human Lung by Respimat® Soft Mist™ Inhaler Compared to Deposition by Metered Dose Inhaler or by Turbuhaler® Dry Powder Inhaler. Journal of Aerosol Medicine. 18(3). 264–272. 115 indexed citations

Hirst, Peter H., Gary R. Pitcairn, Thomas E. Tarara, et al.. (2002). In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler. Pharmaceutical Research. 19(3). 258–264. 68 indexed citations

Newman, Stephen P., et al.. (2002). Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler. Respiratory Medicine. 96(12). 1026–1032. 28 indexed citations

10.

Hirst, Peter H., et al.. (2001). A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler®and pMDI plus spacer in asthmatic patients. Respiratory Medicine. 95(9). 720–727. 61 indexed citations

11.

Hirst, Peter H., et al.. (2001). Deposition and Pharmacokinetics of Flunisolide Delivered from Pressurized Inhalers Containing Non-CFC and CFC Propellants. Journal of Aerosol Medicine. 14(2). 197–208. 54 indexed citations

12.

Hirst, Peter H., Gary R. Pitcairn, Jeffrey C. Richards, et al.. (2001). Deposition and Pharmacokinetics of an HFA Formulation of Triamcinolone Acetonide Delivered by Pressurized Metered Dose Inhaler. Journal of Aerosol Medicine. 14(2). 155–165. 21 indexed citations

13.

Newman, Stephen P., et al.. (2000). Scintigraphic comparison of budesonide deposition from two dry powder inhalers. European Respiratory Journal. 16(1). 178–183. 102 indexed citations

14.

Pitcairn, Gary R., et al.. (2000). Pulmonary Drug Delivery from the Taifun Dry Powder Inhaler Is Relatively Independent of the Patient's Inspiratory Effort. Journal of Aerosol Medicine. 13(2). 97–104. 45 indexed citations

15.

Pitcairn, Gary R., et al.. (2000). Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler. Clinical Therapeutics. 22(12). 1483–1493. 28 indexed citations

16.

Newman, Stephen P., et al.. (1999). Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes☆☆☆. Journal of Allergy and Clinical Immunology. 104(6). s253–s257. 16 indexed citations

17.

Ishibashi, Tatsuro, Gary R. Pitcairn, Hideaki Yoshino, Masakazu Mizobe, & Ian R. Wilding. (1998). Scintigraphic Evaluation of a New Capsule-Type Colon Specific Drug Delivery System in Healthy Volunteers. Journal of Pharmaceutical Sciences. 87(5). 531–535. 30 indexed citations

18.

Pitcairn, Gary R. & Stephen P. Newman. (1997). Tissue Attenuation Corrections in Gamma Scintigraphy. Journal of Aerosol Medicine. 10(3). 187–198. 85 indexed citations

19.

Pitcairn, Gary R., et al.. (1997). Scintigraphic Assessment of Drug Delivery from the Ultrahaler Dry Powder Inhaler. Journal of Aerosol Medicine. 10(4). 295–306. 33 indexed citations

20.

Pitcairn, Gary R., et al.. (1995). Lung Deposition of Salbutamol from the Leiras Metered Dose Powder Inhaler. Journal of Aerosol Medicine. 8(3). 307–311. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact